Empresa Wayland Group Corp. Canadian Securities Exchange
Acciones
WAYL
CA9442041062
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2016 | Peso | 2017 | Peso | Delta |
---|---|---|---|---|---|
Marijuana Production for Medical Purposes
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -18,98 % |
Ventas por región
USD en millones | 2016 | Peso | 2017 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 3 | 100,0 % | 2 | 100,0 % | -18,98 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | - | |
Geoff Kosar
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 237 260 499 | 237 260 499 ( 100,00 %) | 0 | 100,00 % |
Información de la empresa
Wayland Group Corp.
845 Harrington Court Unit 3
L7N 3P3, Burlington
+289-288-6274
Varia. 1 de ene. | Capi. | |
---|---|---|
+40,09 % | 6157,69 M | |
-16,34 % | 4462,61 M | |
-7,11 % | 3268,89 M | |
+5,14 % | 3197,81 M | |
-0,18 % | 2599,21 M | |
+47,93 % | 1975,39 M | |
-7,15 % | 1697,69 M | |
+0,67 % | 1661,22 M | |
-8,73 % | 1609,03 M |